BIOMERICA INC Revenue Recognition, Sales Returns, Reserve for Sales Returns
BIOMERICA INC (BMRA) reported Revenue Recognition, Sales Returns, Reserve for Sales Returns of $0 for the 3-month period ending 2019-02-28, per its 10-Q filed 2019-04-15.
Discontinued › Notes
us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns · last filed 2019-04-15
- BIOMERICA INC revenue recognition, sales returns, reserve for sales returns for the quarter ending 2019-02-28 was $0.00.
- BIOMERICA INC revenue recognition, sales returns, reserve for sales returns for the quarter ending 2018-11-30 was $0.00.
- BIOMERICA INC revenue recognition, sales returns, reserve for sales returns for the quarter ending 2018-08-31 was $0.00.
- BIOMERICA INC revenue recognition, sales returns, reserve for sales returns for the quarter ending 2018-05-31 was $0.00.
- BIOMERICA INC revenue recognition, sales returns, reserve for sales returns for fiscal 2017 was $0.00.
- BIOMERICA INC revenue recognition, sales returns, reserve for sales returns for fiscal 2016 was $0.00.
- BIOMERICA INC revenue recognition, sales returns, reserve for sales returns for fiscal 2015 was $0.00.
- BIOMERICA INC revenue recognition, sales returns, reserve for sales returns for fiscal 2014 was $0.00.
| Period end | Revenue Recognition, Sales Returns, Reserve for Sales Returns 3 month | Revenue Recognition, Sales Returns, Reserve for Sales Returns 6 month | Revenue Recognition, Sales Returns, Reserve for Sales Returns 9 month | Revenue Recognition, Sales Returns, Reserve for Sales Returns 12 month |
|---|---|---|---|---|
| 2019-02-28 | $0.00 10-Q · filed 2019-04-15 | $0.00 derived: sum of 2 quarters · filed 2019-04-15 | $0.00 derived: sum of 3 quarters · filed 2019-04-15 | $0.00 derived: sum of 4 quarters · filed 2019-04-15 |
| 2018-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-14 | $0.00 10-Q · filed 2019-01-14 | $0.00 derived: sum of 3 quarters · filed 2019-04-15 | $0.00 derived: sum of 4 quarters · filed 2019-04-15 |
| 2018-08-31 | $0.00 10-Q · filed 2018-10-15 | $0.00 derived: sum of 2 quarters · filed 2019-04-15 | $0.00 derived: sum of 3 quarters · filed 2019-04-15 | $0.00 derived: sum of 4 quarters · filed 2019-04-15 |
| 2018-05-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2019-04-15 | $0.00 derived: sum of 2 quarters · filed 2019-04-15 | $0.00 derived: sum of 3 quarters · filed 2019-04-15 | $0.00 10-Q · filed 2019-04-15 |
| 2018-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-16 | $0.00 derived: sum of 2 quarters · filed 2018-04-16 | $0.00 10-Q · filed 2018-04-16 | |
| 2017-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-17 | $0.00 10-Q · filed 2018-01-17 | ||
| 2017-08-31 | $0.00 10-Q · filed 2017-10-16 | |||
| 2017-05-31 | $0.00 10-K · filed 2018-08-29 | |||
| 2016-05-31 | $0.00 10-K · filed 2017-08-29 | |||
| 2015-05-31 | $0.00 10-K · filed 2016-08-29 | |||
| 2014-05-31 | $0.00 10-K · filed 2015-08-31 | |||
| 2013-05-31 | $0.00 10-K · filed 2014-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |